GVB: No vaccine technology is currently capable of competing with the type of protective immunity that a pandemic confers to the population. The resulting herd immunity is typically broadly protective

& sterilizing & dramatically reduces viral transmission. No single vaccine can provide protective population immunity when used during a pandemic. Mass vaccination campaigns have opposite effect

Critical you should know again:

1)No clinical trials to date by any vaccine company (Moderna or Pfizer) has shown the COVID gene injections reduce hospitalization or death

2)the bivalent boosters have not been tested in humans, only on mice

3)the bivalent boosters actually caused the mice to be infected and to get ill

The C-19 mass vaccination program has clearly illustrated that vaccination does not work in an environment where the virus rapidly spreads and merely promotes natural selection and expansion in prevalence of viral variants that escape potentially neutralizing vaccine-induced Abs. No vaccine technology is currently capable of competing with the type of protective immunity that a pandemic confers to the population. The resulting herd immunity is typically broadly protective and sterilizing and therefore dramatically reduces viral transmission. No single vaccine can provide protective population immunity when used during a pandemic. Mass vaccination campaigns result in a type of population immunity that has exactly the opposite effect in that they promote viral transmission by virtue of natural selection of more infectious immune escape variants.

As trained innate immunity is a cornerstone of herd immunity, all efforts to protect the population should focus on enabling herd immunity in ways that keep hospitalization and morbidity rates as low as possible. Vaccines will ultimately have the opposite effect whereas strengthening the population’s innate immune system (via healthy lifestyle) while avoiding overcrowding combined with use of nasal-oral hygienic washes (povidone Iodine 10% or hydrogen peroxide diluted) and early outpatient treatment of  those with a weakened innate immune system (e.g., the elderly and those with underlying disease) are the holy grail for effectively and rapidly driving the virus into endemicity and minimizing the toll on human lives.